NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 151-175 out of 3555.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

Public Release: 9-Dec-2014
Psychological Science
Distraction, if consistent, does not hinder learning
A new study challenges the idea that distraction is necessarily a problem for learning. Researchers at Brown University found that if attention was as divided during recall of a motor task as it was during learning the task, people performed as if there were no distractions at either stage.
NIH/National Institute of General Medical Sciences

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 9-Dec-2014
Study of malaria parasites receives 4-year NIH grant of up to $1.8 million
The National Institutes of Health awarded Texas Biomedical Research Institute staff scientist Ian Cheeseman, Ph.D., over $450,000 in first-year funding and is expected to receive up to $1.8 million over four years to continue research into a new method for sequencing the genomes of individual malaria parasites.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Lisa Cruz
lcruz@txbiomed.org
210-724-1691
Texas Biomedical Research Institute

Public Release: 9-Dec-2014
PLOS Biology
Paying attention makes touch-sensing brain cells fire rapidly and in sync
Whether we're paying attention to something we see can be discerned by monitoring the firings of specific groups of brain cells. Now, new work from Johns Hopkins shows that the same holds true for the sense of touch. The study brings researchers closer to understanding how animals' thoughts and feelings affect their perception of external stimuli.
NIH/National Institute of Neurological Disorders and Stroke, NIH/National Eye Institute, Office of Naval Research's Multidisciplinary University Research Initiatives Program

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine

Public Release: 9-Dec-2014
Annals of Epidemiology
Smoking still causes large proportion of cancer deaths in the United States
A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States.
NIH/National Cancer Institute, American Cancer Society

Contact: David Sampson
david.sampson@cancer.org
American Cancer Society

Public Release: 9-Dec-2014
PLOS Biology
Birdsong study reveals how brain uses timing during motor activity
Timing is key for brain cells controlling a complex motor activity like the singing of a bird, finds a new study published by PLOS Biology. The findings are the first to suggest that fine-scale timing of neurons is at least as important in motor systems as in sensory systems, and perhaps more critical.
National Institutes of Health, National Science Foundation, James S. McDonnell Foundation

Contact: Megan McRainey
megan.mcrainey@emory.edu
404-727-6167
Emory Health Sciences

Public Release: 9-Dec-2014
PLOS ONE
Altered movement of white blood cells may predict sepsis in patients with major burns
A team of Massachusetts General Hospital investigators has identified what may be a biomarker predicting the development of the dangerous systemic infection sepsis in patients with serious burns.
National Institutes of Health

Contact: Terri Ogan
togan@partners.org
617-726-0954
Massachusetts General Hospital

Public Release: 9-Dec-2014
2014 San Antonio Breast Cancer Symposium
Common chemotherapy is not heart toxic in patients with BRCA1/2 mutations
Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations -- despite preclinical evidence that such treatment can damage the heart.
National Institutes of Health

Contact: Karen Teber
km463@georgetown.edu
215-514-9751
Georgetown University Medical Center

Public Release: 8-Dec-2014
Journal of Clinical Oncology
Experience counts with radiation therapy for head and neck cancer, study shows
Radiation therapy for head and neck cancer is highly complex, and a new study published in the Journal of Clinical Oncology with an accompanying editorial suggests that medical centers with more experience centers have better patient outcomes.
NIH/National Cancer Institute

Contact: Darrell E. Ward
darrell.ward@osumc.edu
614-293-3737
Ohio State University Wexner Medical Center

Public Release: 8-Dec-2014
JAMA Pediatrics
Hookah smoking increases risk of subsequent cigarette smoking among adolescents
A team of researchers at Dartmouth College and University of Pittsburgh found respondents who had smoked water pipe tobacco but not smoked cigarettes were at increased risk of cigarette smoking two years later as recently published online in JAMA Pediatrics.
NIH/National Cancer Institute, NIH/National Center for Advancing Translational Sciences

Contact: Kirk Cassel
Kirk.A.Cassels@Hitchcock.org
603-653-6177
The Geisel School of Medicine at Dartmouth

Public Release: 8-Dec-2014
Journal of Aging and Health, European Journal of Aging
Low-crime, walkable neighborhoods promote mental health in older Latinos
Older Latinos living in the US who perceive their neighborhoods as safer and more walkable are less likely to develop severe depressive symptoms, and the effect may be long term, a new study suggests.
National Institutes of Health

Contact: Sharita Forrest
slforres@illinois.edu
217-244-1072
University of Illinois at Urbana-Champaign

Public Release: 8-Dec-2014
Blood
PRM-151 therapy well tolerated in patients with advanced myelofibrosis
A study that investigated the potential of the compound PRM-151 for reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis has shown initial positive results. Myelofibrosis is a life-threatening bone marrow cancer.
Promedior Inc., National Institutes of Health

Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center

Public Release: 8-Dec-2014
Proceedings of the National Academy of Sciences
Toughest breast cancer may have met its match
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these patients with traditional chemotherapy drugs that only show long-term effectiveness in 20 percent of women with triple-negative breast cancer.
Department of Defense (Maryland Department of Health and Mental Hygiene, Cindy Rosencrans Fund for Triple Negative Breast Cancer, Women Together Fighting Cancer Organization, NIH/National Cancer Institute

Contact: Cathy Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine

Public Release: 8-Dec-2014
Substance Use and Misuse
Does smoking hamper treatment for alcohol abuse?
A new study has shown that smoking can inhibit the success of treatment for alcohol abuse, putting people who are addicted to both tobacco and alcohol in a double bind.
NIH/National Institute on Alcohol Abuse and Alcoholism

Contact: Cathy Wilde
cwilde@ria.buffalo.edu
716-887-3365
University at Buffalo

Public Release: 8-Dec-2014
Rapid Ebola test is focus of NIH grant to Rutgers scientist
Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola. Alland and Cepheid previously used technology similar to the planned Ebola test to develop a rapid test for tuberculosis that is now widely used in impoverished areas of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rob Forman
robert.forman@rutgers.edu
973-972-7276
Rutgers University

Public Release: 8-Dec-2014
Proceedings of the National Academy of Sciences
Detecting gases wirelessly and cheaply
MIT chemists have devised a new way to wirelessly detect hazardous gases and environmental pollutants, using a simple sensor that can be read by a smartphone.
US Army Research Laboratory, US Army Research Office through the MIT Institute for Soldier Nanotechnologies, MIT Deshpande Center for Technological Innovation, NIH/National Cancer Institute

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 8-Dec-2014
Nature Communications
Solid-state proteins maximize the intensity of fluorescent-protein-based lasers
The same research team that developed the first laser based on a living cell has shown that use of fluorescent proteins in a solid form rather than in solution greatly increases the intensity of light produced, an accomplishment that takes advantage of natural protein structures surrounding the light-emitting portions of the protein molecules.
National Science Foundation, National Institutes of Health, Department of Defense, Korea National Research Foundation grant

Contact: Cassandra Aviles
cmaviles@partners.org
617-724-6433
Massachusetts General Hospital

Public Release: 8-Dec-2014
Pediatrics
New research shows fewer deaths related to RSV than previously thought
It's a virus that has long been characterized as dangerous and even deadly, but new research shows infant deaths from respiratory syncytial virus are actually quite uncommon in the 21st century. Researchers at the University of Utah have shown there are approximately 42 deaths annually associated with RSV in the United States -- much lower than previously thought -- and of those deaths, the majority are in infants and young children that have complex preexisting chronic conditions.
National Institutes of Health, H.A. and Edna Benning Presidential Endowment

Contact: Kathy Wilets
kathy.wilets@hsc.utah.edu
801-581-5717
University of Utah Health Sciences

Public Release: 8-Dec-2014
JAMA Pediatrics
Preeclampsia during mother's pregnancy associated with greater autism risk
Children with autism spectrum disorder were more than twice as likely to have been exposed in utero to preeclampsia, and the likelihood of an autism diagnosis was even greater if the mother experienced more severe disease, a large study by researchers with the UC Davis MIND Institute has found.
NIH/National Institute of Environmental Health Sciences, NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development, US Environmental Protection Agency through Science to Achieve Results, UC Davis MIND Institute

Contact: Phyllis Brown
phyllis.brown@ucdmc.ucdavis.edu
916-734-9023
University of California - Davis Health System

Public Release: 8-Dec-2014
Cancer Cell
New agent causes small cell lung tumors to shrink in pre-clinical testing
Small cell lung cancer -- a disease for which no new drugs have been approved for many years -- has shown itself vulnerable to an agent that disables part of tumor cells' basic survival machinery, researchers at Dana-Farber Cancer Institute and the Massachusetts Institute of Technology reported.
The National Institutes of Health, The Thoracic Foundation, The Susan Spooner Foundation, Massachusetts Institute of Technology-Dana-Farber Cancer Institute Bridge grant, the Danish Cancer Society.

Contact: Anne Doerr
Anne_Doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Public Release: 8-Dec-2014
56th American Society of Hematology Annual Meeting
Disorder in gene-control system is a defining characteristic of cancer, study finds
The genetic tumult within cancerous tumors is more than matched by the disorder in one of the mechanisms for switching cells' genes on and off, scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard report in a new study. Their findings, published online today in the journal Cancer Cell, indicate that the disarray in the on-off mechanism -- known as methylation -- is one of the defining characteristics of cancer and helps tumors adapt to changing circumstances.
NIH/National Cancer Institute, NIH/National Heart Lung and Blood Institute, Blavatnik Family Foundation, Stand Up to Cancer, Melton and Rosenbach Funds, American Cancer Society, National Science Foundation, Leukemia and Lymphoma Society

Contact: Anne Doerr
Anne_Doerr@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute

Public Release: 8-Dec-2014
Proceedings of the National Academy of Sciences
Heat-shock protein enables tumor evolution and drug resistance in breast cancer
Long known for its ability to help organisms successfully adapt to environmentally stressful conditions, the highly conserved molecular chaperone heat-shock protein 90 also enables estrogen receptor-positive breast cancers to develop resistance to hormonal therapy.
National Institutes of Health, National Cancer Institute, Susan G. Komen Foundation, Howard Hughes Medical Institute

Contact: Matt Fearer
fearer@wi.mit.edu
617-452-4630
Whitehead Institute for Biomedical Research

Public Release: 8-Dec-2014
Nature
Genetic errors linked to aging underlie leukemia that develops after cancer treatment
New research at Washington University School of Medicine in St. Louis challenges the view that cancer treatment in itself is a direct cause of a fatal form of leukemia that can develop several years after a patient receives chemotherapy or radiation therapy.
NIH/National Human Genome Research Institute, Leukemia & Lymphoma Society.

Contact: Diane Duke Williams
williamsdia@wustl.edu
314-286-0111
Washington University School of Medicine

Public Release: 8-Dec-2014
Proceedings of the National Academy of Sciences
New therapy holds promise for restoring vision
UC Berkeley scientists developed a therapy to restore light sensitivity to retinas blinded by the death of photoreceptors, as in retinitis pigmentosa. They use a virus to insert a gene for an ion channel into surviving retinal cells. An injected chemical binds to the receptor and opens it when hit with light, making these cells respond to light. It works in mice and now dogs at PennVet, while mice see enough to follow visual cues.
National Institutes of Health, Foundation Fighting Blindness

Contact: Robert Sanders
rlsanders@berkeley.edu
510-643-6998
University of California - Berkeley

Public Release: 8-Dec-2014
Proceedings of the National Academy of Sciences
Vaccine holds hope of preventing antibiotic resistant skin infections
LA BioMed researchers find a new investigational vaccine, NDV-3, employing the recombinant protein Als3, can mobilize the immune system to fight off MRSA skin infections in an experimental model.
National Institutes of Health, US Department of Defense, NovaDigm Therapeutics, Inc.

Contact: Laura Mecoy
Lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)

Public Release: 8-Dec-2014
Journal of Cell Biology
Macrophages chase neutrophils away from wounds to resolve inflammation
Macrophages are best known for their Pac Man-like ability to gobble up cellular debris and pathogens in order to thwart infection. A new study describes how these immune cells also help resolve inflammation by inducing white blood cells called neutrophils to leave wounded tissue.
American Heart Association, National Institutes of Health

Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press

Showing releases 151-175 out of 3555.

<< < 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.